J. Rymenants

Antiviral treatment of SARS-CoV-2-infected hamsters reveals a weak effect of favipiravir and a complete lack of effect for hydroxychloroquine

B. Weynand, B. Hens, L. Delang, 2020, bioRxiv.

Evaluation of virucidal activity of residual quaternary ammonium-treated surfaces on SARS-CoV-2

D. Purcell, J. McAuley, D. Foucher, 2021, American Journal of Infection Control.

Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in-vitro repurposing screen

F. Musiani, Daniela Iaconis, V. Summa, 2020, bioRxiv.

A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo

Jian Li, J. Neyts, Hong Liu, 2021, Viruses.